State must walk a fine line between playing the green card in Washington and standing tall alongside EU colleagues ...
Eli Lilly is betting big on its experimental oral weight-loss drug even before reporting data from its late-stage trial by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results